Table 1 Patients’ characteristics stratified by biochemical recurrence using PSA 0.2 ng/mL definition
BCR (-) (n = 150) | BCR (+) (n = 53) | Total (n = 203) | p value | |
|---|---|---|---|---|
Age (year) | ||||
Median (range) | 70.0 (51–80) | 69.0 (55–79) | 70.0 (51–80) | 0.654§ |
PSA at diagnosis (ng/mL) | ||||
Median (range) | 7.4 (3.1-32.1) | 7.2 (3.7-16.0) | 7.4 (3.1-32.1) | 0.834§ |
Biopsy gleason score | ||||
6 or less | 92 | 34 | 126 | |
7 | 50 | 18 | 68 | |
8-10 | 8 | 1 | 9 | 0.576* |
Clinical T stage | ||||
T1c | 95 | 29 | 124 | |
T2a | 44 | 20 | 64 | |
T2b | 8 | 2 | 10 | |
T2c | 3 | 2 | 5 | 0.563* |
Neo-Adjuvant/Adjuvant | ||||
None | 104 | 37 | 141 | |
Neo-Ad (+) | 38 | 15 | 53 | |
Ad (+) | 4 | 1 | 5 | |
Neo-Ad (+), Ad (+) | 4 | 0 | 4 | 0.650* |
EBRT | ||||
No | 102 | 44 | 146 | |
Yes | 48 | 9 | 57 | 0.025* |